SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-23-021706
Filing Date
2023-02-14
Accepted
2023-02-14 16:29:43
Documents
2
Group Members
JEREMY C. GREENREDMILE BIOPHARMA INVESTMENTS III, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm236041d18_sc13ga.htm SC 13G/A 87291
2 EXHIBIT 99.1 tm236041d18_ex99-1.htm EX-99.1 5573
  Complete submission text file 0001104659-23-021706.txt   94568
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 206-337-1030
Zymeworks Inc. (Subject) CIK: 0001937653 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93790 | Film No.: 23630114
SIC: 2834 Pharmaceutical Preparations